Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.85B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.78B |
| 3 |
Mercado Libre
MELI
|
+$1.73B |
| 4 |
TSMC
TSM
|
+$1.2B |
| 5 |
Amgen
AMGN
|
+$1.15B |
Top Sells
| 1 |
Mastercard
MA
|
+$2.6B |
| 2 |
Apple
AAPL
|
+$1.29B |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$1.25B |
| 4 |
Twilio
TWLO
|
+$1.22B |
| 5 |
EPAM Systems
EPAM
|
+$1.12B |
Sector Composition
| 1 | Technology | 18.61% |
| 2 | Healthcare | 9.76% |
| 3 | Financials | 9.05% |
| 4 | Consumer Discretionary | 8.4% |
| 5 | Communication Services | 6.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3351
National Beverage
FIZZ
$3.56B
| $6.51M | ﹤0.01% |
149,637
+2,756
| +2% | +$120K |
|
3352
ProShares Short Dow30
DOG
$129M
| $6.51M | ﹤0.01% |
199,058
-789,203
| -80% | -$25.8M |
|
3353
Monro
MNRO
$542M
| $6.5M | ﹤0.01% |
146,588
+20,497
| +16% | +$909K |
|
3354
ALX Oncology
ALXO
$64.8M
| $6.5M | ﹤0.01% |
384,518
+129,818
| +51% | +$2.19M |
|
3355
First Trust Global Wind Energy ETF
FAN
$179M
| $6.49M | ﹤0.01% |
328,377
-65,537
| -17% | -$1.29M |
|
|
PPT
3356
Putnam Premier Income Trust
PPT
$356M
| $6.47M | ﹤0.01% |
1,620,435
+41,242
| +3% | +$165K |
|
3357
FibroGen
FGEN
$45.7M
| $6.47M | ﹤0.01% |
21,517
+10,339
| +92% | +$3.11M |
|
3358
Invesco Dorsey Wright Emerging Markets Momentum ETF
PIE
$120M
| $6.46M | ﹤0.01% |
276,657
+41,212
| +18% | +$963K |
|
3359
Marcus & Millichap
MMI
$1.23B
| $6.46M | ﹤0.01% |
122,620
-45,787
| -27% | -$2.41M |
|
3360
Central Garden & Pet Co Class A
CENTA
$1.97B
| $6.46M | ﹤0.01% |
197,840
-61,674
| -24% | -$2.01M |
|
3361
Perdoceo Education
PRDO
$2.27B
| $6.46M | ﹤0.01% |
562,194
+95,529
| +20% | +$1.1M |
|
3362
Post Holdings
POST
$5.64B
| $6.45M | ﹤0.01% |
93,143
-169,341
| -65% | -$11.7M |
|
|
YMAB
3363
DELISTED
Y-mAbs Therapeutics
YMAB
| $6.43M | ﹤0.01% |
541,561
+251,177
| +86% | +$2.98M |
|
3364
Cross Country Healthcare
CCRN
$444M
| $6.43M | ﹤0.01% |
296,880
+97,291
| +49% | +$2.11M |
|
3365
ePlus
PLUS
$1.97B
| $6.43M | ﹤0.01% |
114,673
-20,446
| -15% | -$1.15M |
|
3366
Nuveen ESG Mid-Cap Growth ETF
NUMG
$413M
| $6.43M | ﹤0.01% |
146,658
+71,584
| +95% | +$3.14M |
|
3367
Zai Lab
ZLAB
$3.63B
| $6.42M | ﹤0.01% |
146,031
-82,026
| -36% | -$3.61M |
|
3368
Sibanye-Stillwater
SBSW
$6.75B
| $6.42M | ﹤0.01% |
395,625
-187,835
| -32% | -$3.05M |
|
|
DCPH
3369
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $6.42M | ﹤0.01% |
692,624
+459,504
| +197% | +$4.26M |
|
3370
Northern Oil and Gas
NOG
$2.45B
| $6.42M | ﹤0.01% |
227,671
-8,058
| -3% | -$227K |
|
3371
Avantis US Equity ETF
AVUS
$9.73B
| $6.41M | ﹤0.01% |
83,169
+39,877
| +92% | +$3.07M |
|
3372
Theravance Biopharma
TBPH
$699M
| $6.41M | ﹤0.01% |
670,004
-809,025
| -55% | -$7.73M |
|
3373
Banc of California
BANC
$2.66B
| $6.4M | ﹤0.01% |
330,783
+98,445
| +42% | +$1.91M |
|
3374
Interparfums
IPAR
$3.26B
| $6.4M | ﹤0.01% |
72,730
-28,896
| -28% | -$2.54M |
|
|
MYOV
3375
DELISTED
Myovant Sciences Ltd.
MYOV
| $6.4M | ﹤0.01% |
480,676
+134,274
| +39% | +$1.79M |
|